| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Elaine J Heron is Director at VXRT and has filed Form 4s across 3 companies. Elaine J Heron's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.8M at current prices.
The biggest single holding is PVLA (~$7.3M) as Director. Net of sales, the PVLA filings show accumulation of 2,400 shares.
Elaine J Heron has 26 Form 4 filings on record from June 2016 to July 2026, across 3 companies: Director at Vaxart (VXRT), 2022–2026; Director at Palvella Therapeutics (PVLA), 2024–2026; Director at Biomarin Pharmaceutical (BMRN), 2016–2024.
The 36 reported transactions were 14 stock awards, 10 option or other derivative awards, 5 option exercises and 3 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $316K and 2 sales worth about $168K.
The largest open-market purchase was 2,400 shares of PVLA at an average $125.00 on February 27, 2026, about $300K.
The largest open-market sale was 1,000 shares of BMRN at an average $96.94 on September 5, 2018, about $97K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | PVLA Palvella Therapeutics, Inc. | Director | Buy | 2,400 | $125.00 | $300,000.00 | +5.3% | -14.2% | - | |
| Nov 17, 2025 | VXRT Vaxart, Inc. | Director | Buy | 40,000 | $0.40 | $15,921.40 | +70.7% | - | - | |
| Sep 5, 2018 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 1,000 | $96.94 | $96,935.00 | -2.3% | - | - | |
| Dec 14, 2017 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 800 | $88.90 | $71,116.00 | -2.0% | - | - |